Oncology News

Cardiorespiratory fitness levels appeared associated with cancer risk and mortality among a cohort of Swedish men, according to study results published in JAMA Network Open.

The rising incidence of colorectal cancer among young adult patients is disturbing but not surprising.

Scoring systems based on behavioral and clinical data outperformed existing scores in predicting risk for hepatocellular carcinoma in patients with chronic hepatitis B virus infection, according to data presented at the EASL Congress.

Treatment with fruquintinib resulted in a significant and clinically meaningful survival benefit when compared with placebo among patients with refractory metastatic colorectal cancer, according to data published in The Lancet.

Among patients with alcoholic-related liver disease in early stages, 15% progressed to decompensation and 22% died within 6 years, according to data presented at EASL Congress.

Next-generation Cologuard exhibited improved colorectal cancer specificity and sensitivity compared with results of the FDA registrational trial that led to approval of the noninvasive screening test, its manufacturer reported.

The addition of pembrolizumab to perioperative chemotherapy failed to significantly extend EFS among patients with locally advanced resectable gastric and gastroesophageal junction adenocarcinoma, according to the agent’s manufacturer.

Prognostic models for risk for postoperative cancer recurrence that omit race and ethnicity as predictors may be less accurate for individuals from historically underserved populations, retrospective study results showed.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

Cumulative exposure to immunomodulators increased the risk for high-grade cervical intraepithelial neoplasia and cervical cancer in women with inflammatory bowel disease, according to data from Alimentary Pharmacology & Therapeutics.